Skip to main content

MoneyWorks4Me

Lyka Labs informs about disclosure

15 Sep 2022 Evaluate

Lyka Labs has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 15, 2022 or Nehal Narendra Gandhi.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1915.10
Dr. Reddys Labs. 1369.00
Cipla 1410.95
Lupin 1995.00
Zydus Lifesciences 1200.00
View more..